{"efta_number": "EFTA01966271", "page_count": 3, "url": "https://epstein-data.com/EFTA01966271", "pdf_url": "https://epstein-data.com/pdf/EFTA01966271.pdf", "pages": [{"efta_number": "EFTA01966271", "page_number": 0, "text_content": "A Science Financier, Jeffrey Epstein, Changes the Course of Evolution at Harvard.\nIf the scientist's job is to ponder the stars, the banker's is to funnel his vision into stellar panels. For\nwhile scientific theory can be enthralling, it's in danger of racking up lost gigabytes and circuitry dust. So\nevery time a smart businessman comes along, with an interest in science, the public should pay\nattention, because not only can it lead to pragmatic accomplishments but can actually change the course\nof scientific enquiry.\nSuch is the case at Harvard. Evolution is always moving, but nowhere has it been more in flux than in\nBrattle Square. Indeed, ten years ago, an unknown financier, called Jeffrey Epstein, set up the Program\nfor Evolutionary Dynamics at Harvard with a $30 million dollar grant. His mission was not to coddle neo-\nDarwinian theorists (because honestly couldn't $30 million be used to say, vaccinate the entire country\nof Zaire?) but to embolden a pragmatic use for the study of natural selection.\nSo in May 2003, with the cooperation of Lawrence Summers, then President of Harvard, the Program for\nEvolutionary Dynamics set up for business and, under the direction of Martin Nowak, a professor of\nMathematics and Biology at Harvard, it revolutionized the way in which evolution is studied and utilized.\nThe Program became one of the first of its kind to study the evolution of micro biology with the use of\nmathematics. It also became the first department to develop a mathematical model of how cancer cells\nevolve as well as infectious bacteria and viruses such as HIV. Now celebrating its 10th anniversary, the\nProgram's models have led to key discoveries in combatting diseases of all kinds and have encouraged\nresearchers around the world to do the same.\nIt all started in early 2000, when an obscure New York hedge fund owner called Jeffrey Epstein with a\npassion for cutting edge science, invited Martin Nowak to organize a conference on the evolution of\nlanguage. Nowak was then Head of the Program of Theoretical Biology at the Institute for Advanced\nStudy at Princeton and had already published a substantial amount of work on the mathematics of the\nHIV virus, infectious bacteria and cancer. Prior to his post at Princeton, Nowak had been the head of the\nmathematical biology group at Oxford University in 1995 and Professor of Mathematical Biology in 1997.\nHis work was not just quixotic and theoretical but keenly implemental.\nBy 2003, Jeffrey Epstein already had a substantial career in science philanthropy. He had supported the\nresearch of many prominent scientists including, Stephen Hawking, Marvin Minsky, Eric Lander, George\nChurch and Nobel laureate physicists, Gerard 't Hooft, David Gross and Frank Wilczek. He was also a\nmember of the New York Academy of Science, a board member of Rockefeller University and actively\ninvolved in the Santa Fe Institute, the Quantum Gravity Program at the University of Pennsylvania, and sat\non the Mind, Brain & Behavior Advisory Committee at Harvard University. Epstein himself was not a scientist\nper se. He had studied physics at the Cooper Union in New York, mathematics at the Courant Institute in New\nYork, leaving both without a degree and moved on to teaching calculus and physics at the Dalton School in\nManhattan. He was then scooped up into options trading on Wall Street and applied his acumen and\nmathematical wit to the markets.\nBut Epstein's heart remained in the pure sciences, fascinated by fundamental questions on the one hand and\neager to apply scientific theory to the real world. It was this combination that drew him to Nowak. For not\nEFTA_R1_00444374\nEFTA01966271\n", "char_count": 3666}, {"efta_number": "EFTA01966271", "page_number": 1, "text_content": "only could Epstein probe a brilliant mind about the origin of life, the origin of evolution, but with his\nconnections at Harvard, found a powerful platform in Nowak to put groundbreaking medical research into\nimmediate practice.\nOne of the diseases that the Program has tackled successfully is colon cancer. In 2012, Martin Nowak and\npost-doctoral students, Benjamin Allen and Ivana Bozic, developed the first mathematical model of how\nhuman colon cancer cells evolve and specifically how they become immune to inhibitor therapy treatment.\nTheir research was conducted at the request of the Pathology and Oncology Department at John Hopkins\nUniversity. The Department was trying to understand how the KRAS gene in colon cancer cells becomes\nactivated after inhibitor drug therapy, making the cells resistant to treatment.\nBy developing a mathematical model of colon cancer cell growth, Nowak and his team, showed how the\nKRAS gene is not actually activated or 'switched on' from inhibitor drugs but rather a small percentage of\ncolon cancer cells with an already activated KRAS gene are immune from the start and evolve to\npredominance as the other cancer cells are destroyed by the inhibitor drug. The discovery was critical in\nchanging the approach to inhibitor drug therapy. Instead of applying drugs in sequence to one another to\nfight secondary and tertiary resistance, the Pathology and Oncology Department at John Hopkins are now\nexploring the necessity of providing a cocktail of inhibitor drugs to capture all colon cancer cell types:\nthose with the activated KRAS gene and those without. The same tailored approach is underway for other\ncancer types.\nIn 2010, Ivana Bozic and Martin Nowak co-authored a pivotal mathematical study that showed that most\nsolid tumors contain 40 to 100 genetic mutations, but that on average only 5 to 15 of those actually drove\ntumor growth. The findings were essential to researchers at John Hopkins and other oncology departments\nbecause it highlighted the importance of isolating only a key minority of mutated tumor cells for effective\ninhibitor treatment.\n\"Mathematics in medical research reveals patterns that are otherwise hidden,\" Jeffrey Epstein remarked,\nwho maintains a frequent presence at the Program. \"It's exhilarating when a mathematician can determine\nmolecular and cellular behavior with the precision of an engineer and share their findings with physicians.\"\nIn that same year, the Program of Evolutionary Dynamics presented to the John Hopkins School\nof Medicine, the Howard Hughes Medical Institute and others, a mathematical model showing the\ngenetic evolution of pancreatic cancer cells from the time of initial mutation to non-primary\nmalignant cells. What they found was surprising: that pancreatic cancer, one of the most lethal\nforms of cancer, is not fast and furious as suspected, but rather slow growing. In fact, given the\namount and type of genetic disparity between the cellular stages, the model showed that it takes\nabout 10 years for an initiating mutation to develop to a parental, non-metastatic founder cell and\nanother 6 years for cells to become malignant.\nThe significance of these findings highlighted the real potential and importance of isolating\npancreatic mutations prior to metastasis, if not in the blood, then as soon as a primary non-\nmetastatic tumor develops.\nOver the last two years, Nowak and his team also collaborated with John Hopkins School of Medicine to\ndevelop an ultimate database to map and predict the effect of drugs on the HIV virus. Similar to cancer,\nresistance to HIV drug cocktails continues to be a major problem for patients and the trial and error of\nEFTA_R1_00444375\nEFTA01966272\n", "char_count": 3696}, {"efta_number": "EFTA01966271", "page_number": 2, "text_content": "clinical trials can be hugely debilitating. By collecting data from thousands of blood tests of antiviral\nactivity from more than 20 anti-HIV drugs, the model calculates each drug's ability to suppress viral\nreplication and avoid resistant, mutant HIV strains. The model also factors in the performance of every\npossible drug combination, dosages, blood types, age, sex and other variables to arrive to the most\nprecisely engineered predictor of results for future patients.\nOstensibly, Epstein's motivation for applied science varies from Nowak's. While Nowak is a practicing\nRoman Catholic, a declared humanist with a desire to serve society, Epstein is first and foremost a problem\nsolver, interested in strategy, intellectual puzzles and interception. His interests are equally devoted to\nphysics, artificial intelligence and the human brain. According to Nowak, he was fascinated with his Game\nTheory of Win Stay, Lose Shift and eager to see how it could be applied to the markets. That is not to say\nthat Epstein doesn't espouse purely humanistic endeavors. He has given thoughtfully to countless\norganizations that help educate underprivileged children, notably in the US Virgin Islands where his\nfoundation is based. But his essence is in uncovering the unsolved, a possible but perhaps, insatiable\nendeavor.\nMuch has been written about the Program for Evolutionary Dynamics and Martin Nowak's theoretical\nwork in the evolution of language, his mathematical exploration of how pre-life evolved into life, and his\nwork on spatial selection, cooperative, game, graph and set theory. Nowak himself is the recipient of the\nfamed Weldon Memorial Prize, the Albert Wander Prize, the Akira Okubo Prize, the David Starr Jordan\nPrize, the Henry Dale Prize and is the author of several books including, Super Cooperators, Altuism,\nEvolution, and Why We Need Each Other to Succeed.\nBut it is the immediate and practical application of evolution that has been Jeffrey Epstein's focus and\nwhile he remains an obscure figure behind the academic spotlight, known now for a scandal for soliciting\nunderage women, which led to an 18 month jail sentence, he is nonetheless the talented catalyst, the\naccelerator for all of this medical discovery. Whatever the disgrace, Jeffrey Epstein's continued bond with\nMartin Nowak and the Program for Evolutionary Dynamics emphasizes that nature is not fastidious, nor\njudgmental, nor is its dynamic always gradual: it can be sparked into being by an unlikely source,\npragmatically driven and above all, errs towards sustainability, no matter how outlying its' gaze.\nEFTA_R1_00444376\nEFTA01966273\n", "char_count": 2627}]}